Gevorg Tamamyan: We Can Do More…
FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
How Sir Cliff Richard Beat Prostate Cancer at 85 and Why He’s Calling for National Screening
Ankyra Therapeutics Appoints Sailaja Battula, PhD, as Chief Scientific Officer
David OMalley: Promising Results From GOG 3026 Trial in Low-Grade Serous Ovarian Cancer
Servier Pharmaceuticals Welcomes Servier México Team to U.S. Office to Advance Strategic Alignment
SPCC Launches On Demand CME Webinars for the Definitive Trial Project
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer
